A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3.
about
Apoptosis in coxsackievirus B3-caused diseases: interaction between the capsid protein VP2 and the proapoptotic protein sivaMolecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease.Biological significance of a human enterovirus B-specific RNA element in the 3' nontranslated region.Mutations in the 5' NTR and the Non-Structural Protein 3A of the Coxsackievirus B3 Selectively Attenuate MyocarditogenicityIncreased Echogenicity and Radiodense Foci on Echocardiogram and MicroCT in Murine Myocarditisc-FLIP-Short reduces type I interferon production and increases viremia with coxsackievirus B3Complement component 3 interactions with coxsackievirus B3 capsid proteins: innate immunity and the rapid formation of splenic antiviral germinal centersInteraction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptorStructure of Swine Vesicular Disease Virus: Mapping of Changes Occurring during Adaptation of Human Coxsackie B5 Virus To Infect SwineThe Crystal Structure of a Coxsackievirus B3-RD Variant and a Refined 9-Angstrom Cryo-Electron Microscopy Reconstruction of the Virus Complexed with Decay-Accelerating Factor (DAF) Provide a New Footprint of DAF on the Virus SurfaceKinetic and Structural Analysis of Coxsackievirus B3 Receptor Interactions and Formation of the A-ParticleCoxsackievirus B3 inhibits antigen presentation in vivo, exerting a profound and selective effect on the MHC class I pathway.Cleavage of Poly(A)-binding protein by coxsackievirus 2A protease in vitro and in vivo: another mechanism for host protein synthesis shutoff?Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: localization to the 5' nontranslated region.Hormonal regulation of CD4(+) T-cell responses in coxsackievirus B3-induced myocarditis in micegamma delta+ T cells regulate major histocompatibility complex class II(IA and IE)-dependent susceptibility to coxsackievirus B3-induced autoimmune myocarditisEvidence of recombination among enterovirusesRoles of tumor necrosis factor alpha (TNF-alpha) and the p55 TNF receptor in CD1d induction and coxsackievirus B3-induced myocarditis.Cytokine production by Vgamma(+)-T-cell subsets is an important factor determining CD4(+)-Th-cell phenotype and susceptibility of BALB/c mice to coxsackievirus B3-induced myocarditis.Expression of immunoregulatory cytokines by recombinant coxsackievirus B3 variants confers protection against virus-caused myocarditisA single coxsackievirus B2 capsid residue controls cytolysis and apoptosis in rhabdomyosarcoma cells.Tumor necrosis factor-alpha promotes myocarditis in female mice infected with coxsackievirus B3 through upregulation of CD1d on hematopoietic cells.The impact of juvenile coxsackievirus infection on cardiac progenitor cells and postnatal heart developmentMolecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and EncephalitisFluoxetine is a potent inhibitor of coxsackievirus replication.Gammadelta T cells promote a Th1 response during coxsackievirus B3 infection in vivo: role of Fas and Fas ligand.Cross-talk between cd1d-restricted nkt cells and γδ cells in t regulatory cell response.Myocarditis, disseminated infection, and early viral persistence following experimental coxsackievirus B infection of cynomolgus monkeysEpidemics of enterovirus infection in Chungnam Korea, 2008 and 2009.Sex chromosome complement contributes to sex differences in coxsackievirus B3 but not influenza A virus pathogenesis.Reduced MCMV Δm157 viral clearance in the absence of TSAd.High prevalence of enteroviral genomic sequences in myocardium from cases of endemic cardiomyopathy (Keshan disease) in China.Histamine H(1) receptor signaling regulates effector T cell responses and susceptibility to coxsackievirus B3-induced myocarditisExpression of human decay-accelerating factor on intestinal epithelium of transgenic mice does not facilitate infection by the enteral routeProgression or resolution of coxsackievirus B4-induced pancreatitis: a genomic analysisChromosome y regulates survival following murine coxsackievirus b3 infection.The role of B lymphocytes in coxsackievirus B3 infection.Discovery of Structurally Diverse Small-Molecule Compounds with Broad Antiviral Activity against Enteroviruses.IL-21R expression on CD8+ T cells promotes CD8+ T cell activation in coxsackievirus B3 induced myocarditisWild-type coxsackievirus infection dramatically alters the abundance, heterogeneity, and immunostimulatory capacity of conventional dendritic cells in vivo
P2860
Q24524880-DC577FDA-3FF6-4443-A8FD-39D9786B53AFQ24537348-3C1097A9-51B5-4CF2-9495-579B4C750C90Q24538606-7CC1DBF9-A6BD-4BD5-9D42-E9F04848EFBDQ27303738-98355C77-7514-4091-9DD9-9D7C7823739BQ27332440-7CE0EE31-2825-4412-B361-5F69FDAAF97EQ27335025-FD842C5B-A8DE-422C-834B-19B7FF0E1D63Q27480895-EB3D365D-3828-4FFD-BCC4-E34BA55B50B9Q27635031-B79B61FE-DCE6-49A1-938E-74DDA7C063C1Q27641911-87A24886-2A2B-4140-A4E6-56D1AEEB30A8Q27673022-A313420F-FC2B-405F-9A12-95F5F36C62B3Q27682154-A34C9EC6-C427-4275-AC15-87CC87FB05EBQ33510911-7F155D66-44F2-4D78-A230-8C3A82B22F5CQ33639744-AF177B03-6422-428B-A353-A9460DFD8E0BQ33804871-D4429AB9-F80E-41FE-B2F1-A98EAC763674Q33813631-8E043164-F931-4B51-8C60-663F3B99B7C1Q33815399-5A957C48-7AF8-413B-8BFE-C98AF3E7BFCEQ33821082-B121117D-3461-481A-AF5C-511D7340F31AQ33833868-86B3387B-F714-42C7-BB04-5BFCFED24482Q33842268-4C2C675E-FB5B-4B14-8F50-733D4C8E67F6Q33853711-89B6CB3E-4270-4944-9A88-166EE464710AQ33877444-D40DE098-AA18-4ABF-A768-D5767F50F3F5Q33905161-63F79FC2-F17A-4F5C-B94B-17A6E016B3CBQ33982587-CC8482F4-EA89-43D4-8EDC-657D5B46423AQ33992691-D29B4678-7F2E-4EBF-AF5B-5762AC284293Q34323429-846065E9-C274-4C20-92B2-92B534D229D8Q34341389-9725CF0C-2B03-420B-BDE9-A3D03D8ED702Q34550454-2C84B532-65DD-4E5E-BEED-C4979FC03AC0Q34990152-9EF120CF-8A5F-4D56-A91B-524CE2C1A842Q35089265-26AD5A79-8710-4619-B821-9A53C589B736Q35184087-46F9E47A-3A98-4D19-9CFC-47562DA09C27Q35188817-B82ACBFD-92B4-410B-A821-3E4ED818EE71Q35566821-090E9192-2908-4CE4-823A-98C96BF6DC00Q35629455-02DC5825-F50C-44BC-BD92-E3DE61B3CA22Q35641009-E3AFB52B-E511-4B44-AA67-3B876F2F920FQ35702835-DF36145D-5AEA-4A41-9C25-E04CB290B621Q35746932-2D394AF0-E2D5-4F8B-B077-91C4496526D6Q35788195-76EDE133-0576-4590-B15A-A2322B58B460Q35880074-980AF255-0C32-4365-8AF6-F15A670A9B11Q35965698-F5CF132A-AAFA-42FB-A4B0-AF0699DE4D2DQ35981115-4F51F8E6-2BCD-48C9-BC63-D7BD5B048865
P2860
A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
A mutation in the puff region ...... variant of coxsackievirus B3.
@ast
A mutation in the puff region ...... variant of coxsackievirus B3.
@en
type
label
A mutation in the puff region ...... variant of coxsackievirus B3.
@ast
A mutation in the puff region ...... variant of coxsackievirus B3.
@en
prefLabel
A mutation in the puff region ...... variant of coxsackievirus B3.
@ast
A mutation in the puff region ...... variant of coxsackievirus B3.
@en
P2093
P2860
P1433
P1476
A mutation in the puff region ...... variant of coxsackievirus B3.
@en
P2093
P2860
P304
P407
P577
1996-11-01T00:00:00Z